Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

50.54
Delayed Data
As of 4:00pm ET
 -1.48 / -2.85%
Today’s Change
41.93
Today|||52-Week Range
63.40
-9.07%
Year-to-Date

Today’s Trading

Previous close52.02
Today’s open52.18
Day’s range50.46 - 52.18
Volume674,134
Average volume (3 months)794,408
Market cap$8.0B
Dividend yield--
Data as of 4:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+49.20%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book6.56

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.96-1.26%
SGENSeattle Genetics Inc-1.10-2.08%
TSROTESARO Inc+0.30+0.25%
IONSIonis Pharmaceutical...-0.50-0.84%
Data as of 4:00pm ET, 09/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts